This finding not only provided insight into the mechanism underlying Rab32 regulation of mitochondrial fission, but also suggested a new potential therapeutic strategy for GBM patients by targeting the Rab32-ERK1/2-Drp1 axis. The gene discussed is MAPK3; the disease is glioblastoma.